Therapeutic strategies for wild-type gastrointestinal stromal tumor: is it different from KIT or PDGFRA-mutated GISTs?
- PMID: 29264430
- PMCID: PMC5723739
- DOI: 10.21037/tgh.2017.11.05
Therapeutic strategies for wild-type gastrointestinal stromal tumor: is it different from KIT or PDGFRA-mutated GISTs?
Conflict of interest statement
Conflicts of Interest: T Nishida has received honoraria for speeches from Novartis, Bayer, Eisai, and Pfizer.
Figures
Comment on
-
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.J Clin Oncol. 2017 Feb 10;35(5):523-528. doi: 10.1200/JCO.2016.68.6733. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029307 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous